News
STOP's monthly newsletter is packed with insights from experts in obesity prevention and treatment, details on upcoming events, and exciting news from our member organizations. The opening Letter from the Director is posted
Recent Letters from the Director
Guest Letter: Metabolic Health Matters: Addressing Obesity and Advancing Solutions in Fatty Liver Disease
Guest Letter: Metabolic Health Matters: Addressing Obesity and Advancing Solutions in Fatty Liver Disease
June 28, 2025
On the second Thursday in June, Global Fatty Liver Day brings overdue attention to one of the most widespread yet overlooked public health threats of our time: fatty liver disease.
Employer Insurance Coverage of Obesity Treatment
Employer Insurance Coverage of Obesity Treatment
May 29, 2025
Limitations in access and coverage of obesity medications has paralleled the advances in the usage of GLP-1s.
Guest Letter: Concerns About Compounded GLP-1 Medications
Concerns About Compounded GLP-1 Medications
April 29, 2025
OAC has long advised our members against using compounded GLP-1’s. The main reason is FDA’s own words about compounding.
Read Past Letters from the Director
